author-photo

F. Caponigro

18

Papers

1159

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

862MO Gene expression profile differentiates short-term and long-term survivors with immunotherapy in patients with recurrent/metastatic head and neck cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1140PA single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
LBA47First line cetuximab and cisplatin with or without paclitaxel in recurrent/metastatic head and neck cancer: A randomized phase IIb trial

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
OC-005: Afatinib versus methotrexate in recurrent/metastatic HNSCC after platinum therapy: LUX-head and neck

2015 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

2015 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (281)
LBA29_PRAFATINIB VERSUS METHOTREXATE (MTX) AS SECOND-LINE TREATMENT FOR PATIENTS WITH RECURRENT AND/OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) WHO PROGRESSED AFTER PLATINUM-BASED THERAPY: PRIMARY EFFICACY RESULTS OF LUX-HEAD & NECK 1, A PHASE III TRIAL

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors

2010 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (7)
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer.

2009 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (23)
715 POSTER Phase I dose-escalation study of brostallicin in combination with cisplatin (cDDP) in patients with advanced solid tumors

2007 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (1)
A phase I study of bortezomib in combination with 5FU/LV plus oxaliplatin in patients (pts) with advanced colorectal cancer (CRC): EORTC 16029

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)